Pharmacological Management of Diabesity: Current and Emerging Therapies

Curr Obes Rep. 2026 Jan 13;15(1):5. doi: 10.1007/s13679-025-00681-5.ABSTRACTPURPOSE OF REVIEW: This review aims to provide a comprehensive synthesis of current clinical evidence on the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RAs

M Martina Galasso

Environment and CVD: moving from Risk Prediction to Risk Management

Curr Atheroscler Rep. 2026 Jan 13;28(1):10. doi: 10.1007/s11883-025-01375-y.ABSTRACTPURPOSE OF REVIEW: We attempt to provide a framework for cardiovascular risk assessment related to environmental pollutants to enhance awareness of risk posed by environmental risk factors and highlight approaches fo

T Tasveer Khawaja

Sex Differences in Atherosclerosis and its Clinical Complications

Curr Atheroscler Rep. 2026 Jan 13;28(1):12. doi: 10.1007/s11883-025-01383-y.ABSTRACTPURPOSE OF REVIEW: This review examines sex- and gender- specific differences in the pathophysiology, presentation, and clinical complications of atherosclerosis. We explore both traditional and emerging risk factors

T Tina K Reddy